Markets Rejoice as Hormuz Deal Reopen Nears, Supportive Moves
Markets edged higher Monday evening as news of a potential Hormuz reopening deal spread, easing supply concerns. At t...
Explore practical ways to improve your business plan for selling, making it more appealing to potential buyers and investors.
24,642 articlesMarkets edged higher Monday evening as news of a potential Hormuz reopening deal spread, easing supply concerns. At t...
U.S. adults now smoke at a record low, but a shift in public-health funding threatens the playbook that drove the dec...
As Treace Medical eyes 2026, investors weigh adoption of Lapiplasty, payer dynamics, and global expansion. This guide...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
The U.S. pledged a historic $1.2 trillion to fix aging infrastructure, but experts warn that funding alone won’t prev...
GM and Ford are expanding into battery storage, boosting competition for Tesla and signaling a broader shift in how a...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...
A government-backed AI initiative is building a data backbone to test nutrition-focused ideas in farming. Early pilot...
Micron stock has swung on memory cycles, auto-chip demand, and big backlog talk. This article examines whether a deal...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...